Latest Paul Janssen Stories
Donation to British schools will help train future leaders in mental health research, policy and practice LONDON, March 4, 2013 /PRNewswire/ -- Janssen Pharmaceutica, NV, ("Janssen") announced today a donation to the Centre for Global Mental Health, a program of the London School of Hygiene & Tropical Medicine and the Institute of Psychiatry at King's College, London, to support the Centre's new Global Mental Health Scholarship Fund. Given as part of Janssen's global Healthy...
TITUSVILLE, N.J., Feb. 5, 2013 /PRNewswire/ -- Janssen Research & Development, LLC, ("Janssen") announced today the publication of a new article that addresses integrated approaches to healthcare solutions. The authors challenge the healthcare industry to expand its thinking beyond product-focused, "magic bullet" drug development and discuss the need for an integrated approach to patient care, including use of devices, tools and services to help a patient's progress. The...
GHENT, Belgium, Jan. 24, 2013 /PRNewswire/ -- Today, Museum Dr. Guislain in Ghent, Belgium, with support from Janssen Research & Development, LLC ("Janssen"), announced they have issued a global call for nominations for the 2013 Dr. Guislain "Breaking the Chains of Stigma" Award. The award honors an individual, project or organization that has made an exceptional contribution to reducing the stigma associated with mental illness. Nominations can be submitted at...
NEW BRUNSWICK, N.J., Jan. 10, 2013 /PRNewswire/ -- The Dr. Paul Janssen Award for Biomedical Research today opens its 2013 call for nominations. This prestigious award recognizes individuals whose scientific research has made, or has the potential to make, significant transformational contributions toward the improvement of human health. Nominations will be accepted until February 28, 2013 at www.pauljanssenaward.com for consideration by an independent selection committee of world...
GHENT, Belgium, July 12, 2012 /PRNewswire/ -- The inaugural Dr. Guislain Award - "Breaking the Chains of Stigma" - and call for nominations is announced today by Museum Dr. Guislain in Ghent, Belgium, with support from Janssen Research & Development, LLC ("Janssen"). The $50,000 award will honor an individual, project or organization that has made an exceptional contribution to reducing the stigma associated with mental illness. Nominations can be submitted at...
BOSTON, June 19, 2012 /PRNewswire/ -- Johnson & Johnson today named Dr. Victor Ambros and Dr. Gary Ruvkun the winners of the 2012 Dr. Paul Janssen Award for Biomedical Research during an event at the Biotechnology Industry Organization International Convention in Boston. Drs. Ambros and Ruvkun won the Award for their co-discovery of microRNAs (miRNAs) as central regulators of gene expression and development. These regulatory molecules have been implicated in a wide range of...
NEW BRUNSWICK, N.J., Dec. 9, 2011 /PRNewswire/ -- The Dr. Paul Janssen Award for Biomedical Research today opens its 2012 call for nominations. This prestigious award recognizes individuals whose scientific research has made, or has the potential to make, significant transformational contributions toward the improvement of human health. Nominations are available at www.pauljanssenaward.com and will be accepted until February 15, 2012, for consideration by an independent selection...
LAUSANNE, Switzerland, November 17, 2011 /PRNewswire/ -- Funds Will be Used to Commercialize a Fully Automated, Compact Molecular Diagnostics System Designed to Drive the Widespread Adoption of Personalized Medicine and Other Diagnostic Applications Including the Fight Against Infectious Disease Biocartis, a company developing and commercializing compact molecular diagnostic (MDx) systems designed to drive the widespread adoption of...
TITUSVILLE, N.J., Nov. 10, 2011 /PRNewswire/ -- Janssen Pharmaceutical Companies of Johnson & Johnson ("Janssen") today announced the launch of Healthy Minds, a comprehensive initiative to accelerate progress in the fight against brain disorders that affect millions of people around the world. Healthy Minds includes a significant new commitment by Janssen Pharmaceuticals, Inc. of $3 million in direct and challenge contributions to the International Mental Health Research Organization...
Largest National Duchenne Organization Continues to Support Cardiac Health with Three New Grants in Duchenne Research to Ohio State and Nationwide Children's Research Institute HACKENSACK, N.J., Sept. 20, 2011 /PRNewswire-USNewswire/ -- Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), has awarded three separate $50,000 exploratory awards to researchers at The Ohio State...
